Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments.
Acorn Biolabs has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Acorn Biolabs's investors include Y Combinator, Creative Destruction Lab (CDL), Real Ventures, Communitech, Accelerator Centre.
Acorn Biolabs is headquartered in Toronto, Canada.
Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments.
Acorn Biolabs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acorn Biolabs — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/acorn-biolabs. Accessed September 2, 2026.
VCBacked. (2024). Acorn Biolabs — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/acorn-biolabs
{{cite web |title=Acorn Biolabs — Funding & Investors |url=https://www.vcbacked.co/company/acorn-biolabs |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated